Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$9.20M$9.20Mderived−2.7% vs Q4 2022 Net Income-$3.63M-$3.63MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$2,993,312N/M Operating Cash Flowderived-$1,854,225N/M Free Cash Flowderived-$1,856,139N/M Margins · derivedOperating margin-32.5%−12.4 pt vs Q4 2022
Net margin-39.5%−16.3 pt vs Q4 2022
ended Dec 31, 2023 · filed Apr 16, 2024 · 107 d after period end